首页> 美国卫生研究院文献>Journal of Pain Research >Intrathecal morphine attenuates acute opioid tolerance secondary to remifentanil infusions during spinal surgery in adolescents
【2h】

Intrathecal morphine attenuates acute opioid tolerance secondary to remifentanil infusions during spinal surgery in adolescents

机译:鞘内注射吗啡可减轻青少年脊髓手术后瑞芬太尼输注继发的急性阿片耐受

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionThe unique pharmacokinetic properties of remifentanil with a context-sensitive half-life unaffected by length of infusion contribute to its frequent use during anesthetic management during posterior spinal fusion in children and adolescents. However, its intraoperative administration can lead to increased postoperative analgesic requirements, which is postulated to be the result of acute opioid tolerance with enhancement of spinal N-methyl-D-aspartate receptor function. Although strategies to prevent or reduce tolerance have included the coadministration of longer acting opioids or ketamine, the majority of these studies have demonstrated little to no benefit. The current study retrospectively evaluates the efficacy of intrathecal morphine (ITM) in preventing hyperalgesia following a remifentanil infusion.
机译:前言瑞芬太尼具有独特的药代动力学特性,其上下文相关的半衰期不受输注时间的影响,这有助于其在儿童和青少年的后路脊柱融合术中的麻醉处理中频繁使用。然而,其术中给药可导致术后止痛需求增加,这被认为是急性阿片类药物耐受性的结果,其脊柱N-甲基-D-天冬氨酸受体功能增强。尽管预防或降低耐受性的策略包括长效阿片类药物或氯胺酮的共同给药,但大多数研究显示几乎没有益处。本研究回顾性评估鞘内注射吗啡(ITM)预防瑞芬太尼输注后的痛觉过敏的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号